Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|February 3, 2007
3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SARJeffrey L Romine, Scott W Martin, Nicholas A Meanwell, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
(S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activityAlexandre L'Heureux, Alain Martel, Huan He, et al.
Archives of Neurology|July 11, 2012
Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsyPavel Klein, Daniel Herr, Phillip L Pearl, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2016
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonistsMatthew D Hill, Haiquan Fang, Sivarao V Digavalli, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 20, 2023
Protocol-Driven Initiation and Weaning of High-Flow Nasal Cannula for Patients With Bronchiolitis: A Quality Improvement InitiativeJia Xin Huang, Blair Colwell, Pranjali Vadlaputi, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicityRobert J Freishtat, Joanne Natale, Angela S Benton, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neuronsYong-Jin Wu, Christopher G Boissard, Jie Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamidesYong-Jin Wu, Li-Qiang Sun, Huan He, et al.
Plos One|August 26, 2014
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's diseasePaul D Wes, Amy Easton, John Corradi, et al.
Molecular Therapy. Nucleic Acids|February 26, 2020
Allele-Selective Knockdown of MYH7 Using Antisense OligonucleotidesBrian R Anderson, Marianne L Jensen, Peter H Hagedorn, et al.
Pageof 3